GlassScriptPhysician profile
Aaron J Wallace
NPI 1275701963
$4,858.70
in general payments reported to CMS, 2019-2025
29 companies · $595 in 2025
The $595 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $334 · 2020: $358 · 2021: $1,529 · 2022: $508 · 2023: $680 · 2024: $854 · 2025: $595.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,129.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,129.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,157.39 | 2019-2025 | Mako, Triathlon, Inspace |
| Amgen INC. | $284.96 | 2019-2023 | Evenity, Prolia |
| Djo, LLC | $199.45 | 2021-2025 | Cmf |
| Orthalign INC | $163.24 | 2024 | Orthalign Plus |
| Trice Medical, INC. | $151.37 | 2023 | |
| Depuy Synthes Sales INC. | $85.59 | 2019-2023 | Orthovisc, Monovisc |
| Horizon Therapeutics Plc | $79.64 | 2021-2022 | |
| Vertex Pharmaceuticals Incorporated | $66.59 | 2025 | |
| Bioventus LLC | $63.11 | 2021-2025 | Exogen Ultrasound Bone Healing System |
| Conformis, INC. | $56.19 | 2019 | |
| Heron Therapeutics, INC. | $55.40 | 2024 | Zynrelef |
| Pacira Pharmaceuticals Incorporated | $51.54 | 2024-2025 | Zilretta, Iovera, Exparel |
| Medtronic, INC. | $46.15 | 2024 | Signia, Plasmablade(Tm) |
| Pacira Therapeutics, INC. | $43.56 | 2020-2021 | |
| Astrazeneca Pharmaceuticals LP | $38.80 | 2023-2025 | Wainua |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $34.32 | 2024-2025 | Vistaseal, Echelon; Endopath |
| Pfizer INC. | $32.38 | 2020 | |
| Innovation Technologies INC | $31.86 | 2025 | Irrisept |
| Organogenesis INC. | $31.05 | 2025 | Puraply Wound Matrix |
| Endo Pharmaceuticals INC. | $30.35 | 2022-2023 | Xiaflex |
| Ferring Pharmaceuticals INC. | $24.68 | 2021-2022 | |
| Davol INC. | $23.76 | 2024 | Arista Ah Flexitip |
| Smith+Nephew, INC. | $22.21 | 2019 | |
| Portola Pharmaceuticals, LLC | $20.54 | 2020 | |
| Kci USA, INC. | $14.55 | 2020 | |
| Convatec INC. | $14.37 | 2022 | |
| Triad Life Sciences INC. | $12.50 | 2021 | |
| Arthrex, INC. | $12.00 | 2019 | |
| Radius Health, INC. | $11.15 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Wallace listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.